🔴 Adaptive Biotechnologies is trading 5% down in pre-market with no clear company-specific catalyst

Adaptive Biotechnologies is trading 4.85% down at $26.51 in pre-market on September 22, 2026, after closing at $27.86 on September 21; no fresh company-specific announcement clearly explains the decline.

• A previously reported insider sale involved 115,406 shares under a Rule 10b5-1 plan.
• BTIG maintained Buy and raised its price target, providing conflicting signals.
• Broader markets are mixed, offering limited explanatory power.